Home/Corridors/DMIC/Vikram Udyogpuri

Vikram Udyogpuri

OperationalMadhya PradeshPhase 1 near full — 20+ units producing, Medical Devices Park
1,100 acresArea
₹5,000 crInvestment potential

Vikram Udyogpuri is the most fully realised DMIC node in the open-source record: Phase 1 (~1,100 ac) is nearly full with 67 industries allotted, 20-plus already in production, and cumulative committed investment above ₹5,000 cr. AMUL is the operational anchor and PepsiCo (₹1,225–1,266 cr, 2,000 jobs) is the largest single named investor, with the figure corroborated across multiple sources.

Its differentiator is a dedicated 350-acre Medical Devices Park — unique among DMIC nodes — where eight manufacturers (CliniSupplies, VRM, HC Lifeline, KRM, Microgen, Bioline and others) are set to launch in 2026 against ~₹254 cr of investment and 2,400 jobs, backed by a NIPER Ahmedabad technical MoU.

Demand has outrun supply: with 200-plus proposals pending and ~₹50,000 cr in the pipeline, MPIDC acquired 400+ ha for Phase 2 in January 2025 and has logged ~₹8,000 cr of fresh intents — though the Phase 2 DPR is still to be prepared and the full 67-name allottee list and employment figures are not public.

Sectors
Medical devices, food processing, pharma & biotech, automobiles, textiles, electronics (ESDM)
Nearest hub
Near Ujjain; SH-18 and the Ujjain–Dewas railway line; within the Pithampur–Dhar–Mhow Investment Region
Developer / SPV
DMIC Vikram Udyogpuri Ltd, incorporated 2010; NICDIT (Centre) + Govt of Madhya Pradesh / MPIDC; AECOM project-management consultant
EPC contractor
Phase 1 trunk infrastructure 98.27% complete (Dec 2020) and operational; 5.2 MLD CETP (~₹24.6 cr); Phase 2 (400+ ha) land acquired Jan 2025, DPR pending
Status
Phase 1 near full — 20+ units producing, Medical Devices Park

Companies & commitments

CompanySectorCommitment
AMUL (Panchmahal Co-op Milk Union)Dairy / food processingOperational — the node’s anchor investor [V]
PepsiCo India HoldingsBeverage-flavouring ingredients₹1,225–1,266 cr · ~22 ac · 2,000 jobs — under construction, operational by ~Q1 2026; largest single named investor [V]
Haier AppliancesConsumer electronics / white goodsOperational (Chinese JV) [V]
Inox Air ProductsIndustrial gasesOperational (among the first ~20 units) [V]
Ashirvad PipesPipes / manufacturingAllotted / under construction [V]
Karnataka Antibiotics / Srinivas Pharma / Symbiotic LifePharma & biotechAllotted [V]
Yashoda LinenTextilesAllotted [V]
CliniSupplies / VRM / HC Lifeline / KRM / Microgen / Bioline (Medical Device Park)Medical devicesPart of ₹254 cr · 2,400 jobs — 8 units set to begin operations 2026 [V]
LTI MindtreeIT services₹500 cr — MoU [V1]
South Korean EDCCancer-detection kits (Medical Device Park)₹207 cr — MoU [V1]

Industries coming up

Medical devicesFood processing & dairyPharmaceuticals & biotechWhite goods / electronicsTextilesEngineering & industrial machinery

Infrastructure & connectivity

Incentives & land: Madhya Pradesh industrial policy benefits (capital subsidy, sector incentives for food processing, pharma, textiles, electronics); central-India location for pan-India distribution; NIPER Ahmedabad technical-support MoU for the Medical Devices Park. Specific subsidy / SGST rates not detailed in the node sources.

An operational node with real production

Unlike Dholera (pre-operational) or IITGNL (limited disclosure), Vikram Udyogpuri has moved past MoUs into commercial production — 20-plus units running, 67 allottees, and Phase 1 nearly sold out. AMUL anchors food processing, Haier and Inox Air Products are operational, and PepsiCo’s ₹1,225–1,266 cr beverage-ingredients plant (2,000 jobs) is the largest single confirmed investment, due on stream around early 2026.

The Medical Devices Park

The 350-acre Medical Devices Park is the node’s signature asset and has no equal among DMIC nodes. Eight manufacturers — CliniSupplies (catheters), VRM (nuclear medicines), HC Lifeline (syringes/cannulas), KRM, Microgen, Meepl, Shreeji Polymers and Bioline — are set to begin operations in 2026 on ~₹254 cr of investment and 2,400 jobs, with NIPER Ahmedabad providing technical support. A South Korean EDC cancer-kit MoU (₹207 cr) adds to the cluster.

Phase 2 and open questions

Demonstrated demand — 200-plus proposals, ~₹50,000 cr pipeline — drove the January 2025 acquisition of 400+ ha for Phase 2 (₹475 cr land cost, ~₹8,000 cr of intents from ~35 firms). The Phase 2 DPR and construction timeline are still to be set.

Disclosure remains partial: only about nine of the 67 Phase 1 allottees are publicly named, and the node’s projected employment figure is not published.

Timeline

Sources